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Introduction
The peak age at presentation for endometrial
carcinoma is approximately sixty years. Ninety percent
of these women present with abnormal vaginal bleeding
and 75% present with stage 1 disease.1 Prognostic
factors, which influence the treatment algorithm in
endometrial carcinoma include grade of tumour,
histological type, depth of myometrial invasion, cervical
involvement and lymphadenopathy.2,3 Prior to 1998
endometrial carcinoma was staged by examination under
anaesthesia, hysteroscopy and dilatation and curettage.
This resulted in understating of 13-22% of cases. Routine
surgical staging (total abdominal hysterectomy and
bilateral salpingo-oophorectomy with peritoneal washes
with or without pelvic and paraaortic lymphadenopathy)
was recommended by FIGO in 1998. Deep myometrial
invasion to the outer half of the myometrium (FIGO
stage 1C) is a poor prognostic factor, which is associated
with an increased risk of pelvic and paraaortic
lymphnode metastases. The recent introduction of less-
invasive surgical techniques requires a more accurate
preoperative work-up to prevent the risk of understaging
the disease and impair the therapeutic plan.4-8 Spread of
tumour to adjacent tissues is assessed by a combination
of clinical and imaging modalities. Cross sectional
imaging such as computed tomography and magnetic
resonance imaging is not officially part of the FIGO
staging, however pelvic MRI, has the advantage of
multiplanar data acquisition and is reported to be
superior to CT and ultrasound because of inherent
excellent soft tissue contrast.9 Many studies9-17 have
shown the excellent accuracy of MR imaging in the
preoperative assessment of the depth of myometrial
invasion, the extent of cervical invasion, and
identification of enlarged pelvic and lumboaortic lymph
nodes separately. Data regarding our part of world is
limited18,19 and it is a relatively new topic for research in
local environment and especially after recent advances in
imaging techniques and availability of MRI equipment. 
The purpose of this study was to evaluate the validity of
MRI in the preoperative staging of endometrial carcinoma in
our population and comparison with surgical and
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Abstract
Objective: To evaluate the accuracy of MRI in staging of endometrial carcinoma, and comparison with
surgery and histopathological findings.
Methods: A one year prospective cross-sectional study was conducted from 10/3/2005 to 31/5/2006, at the
Radiology department, Aga Khan University Hospital (AKUH) Karachi. Fifty two patients with diagnosis of
endometrial carcinoma, referred to radiology department for preoperative staging by MRI and had undergone
surgery were included.
Results: MRI was found to be 79% sensitive, 85% specific and 80% accurate for staging endometrial
carcinoma while PPV and NPV were 97% and 66% respectively.
Conclusion: Magnetic resonance imaging is a good, safe, accurate and non invasive imaging modality in
staging of endometrial carcinoma. It can be used as a first line radiological investigation in patients with
endometrial carcinoma for treatment planning (JPMA 59:622; 2009).
histopathological findings. 
Patients and Methods
Between April 2005 and March 2006, a total of 52
patients with endometrial adenocarcinoma, histologically
documented by endometrial biopsy were referred to our
department for MRI examination of the pelvis. These patients
included outside referrals as well as inpatients. Informed
consent was obtained from all patients. Patients with
histologically proven endometrial adenocarcinoma were
included in the study. Finally 50 patients were studied.
Twenty patients were premenopausal and thirty were
postmenopausal. Most common clinical presentation was
postmenopausal bleeding (60%) followed by intermenstural
bleeding (24%) and only 16% patients presented with
postcoital bleeding. At histologic examination, 41 of 50
tumours were endometrioid adenocarcinoma, 5 were
papillary serous adenocarcinoma and 4 were adenocarcinoma
with squamous differentiation. All patients underwent
surgery. Forty-four patients underwent type II radical
hysterectomy, four type III hysterectomy and two had type 1
hysterectomy. Eleven patients were subjected to pelvic lymph
node sampling, and ten patients had systematic pelvic and
lumboaortic lymphadenectomy. MR imaging studies were
performed with a 1.5-T superconducting magnet. The pelvic
phased-array coil was used in all patients. Transverse T1-
weighted, Transverse T2-weighted, Sagittal T2-weighted,
short-axis (perpendicular to the main axis of the body of the
uterus) T2-weighted RARE, dynamic MR imaging, after the
administration of 0.1 mmol gadolinium per kilogram of body
weight, was performed by using a quadraphasic technique,
which enables acquisition of images at four phases
(precontrast, arterial, venous, and equilibrium) relative to the
injection of the contrast material. Dynamic imaging was
performed by using a fast multiplanar spoiled gradient-echo
(FMSPGR) pulse sequence. Images were reviewed on
working console as well as on hard copies. 
MR images were analyzed for, tumour signal intensity
on T1- and T2-weighted images compared with that of adjacent
myometrium, visibility of the junctional zone on T2-weighted
images as a band of low signal intensity immediately subjacent
to the endometrial stripe, the pattern of uterine enhancement at
dynamic imaging, categorized as subendometrial
enhancement, myometrial infiltration detected on T2-weighted
images on the basis of disruption or discontinuity of the
junctional zone and/or irregular myometrial enhancement at
the endometrium-myometrium interface in all three types of
myometrial enhancement, infiltration of the uterine cervix,
detected as a high-signal-intensity mass within the
endocervical canal and/or disruption of the normal low-signal-
intensity cervical stroma and presence of enlarged pelvic
and/or lumboaortic lymph nodes (cutoff value, 10 mm along
the minimal transverse diameter). Quantitative image analysis
included the signal-to-noise ratio in the tumour and
myometrium during all phases of the dynamic study. Final
MRI report was made by consultant radiologist having
experience in MRI. Preoperative findings of all patients who
underwent surgery were also recorded. Surgical specimens
were sectioned along the longitudinal plane of the uterus. The
depth of myometrial invasion was estimated grossly, and
confirmed microscopically without knowledge of MR
findings, and classified according to International Federation of
Gynecology and Obstetrics classification. The total number of
lymph nodes, their site, and the number of metastatic lymph
nodes were subsequently documented by histopathologist. The
imaging findings were compared with histologic and operative
findings. Predefined Performa was used for data collection,
data entered and analyzed by using computer program SPSS
(version 15). Sensitivity, specificity, accuracy, NPV and PPV
of MRI for staging endometrial carcinoma was calculated.
Results
MRI accurately staged presence of myometrial
invasion in 39 (78%) and absence of myometrial invasion in 5
(10%) out of 50 patients (Table), stage IA (5), stage IB (20),
stage IC (9), stage IIA (8), stage IIIC (1), stage IIB (1) which
was statged as IIA although it was correctly diagnosed
myometrial invasion. Myometrial invasion was under
diagnosed in 5 (10%) patients. They were IB (less than 50%
myometrial invasion) on surgery/histological staging and they
were staged as IA. Cases which were IB were staged as IA. The
reasons were that the bulky polypoid tumour distended the
endometrial cavity thus attenuating myometrial tissue. One
patient had a small uterus, less than 4 cms in longitudinal
diameter and demonstrated marked thinning of myometrium.
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Table: Accuracy of MRI in staging of endometrial carcinoma.
Author Total patients Sensitivity Specificity Positive predictive value Negative predictive value Accuracy
Eun Jung Lee,4 46 Not mentioned Not mentioned Not mentioned Not mentioned 80%
Pakkal MV,20 28 Not mentioned Not mentioned Not mentioned Not mentioned 78%
Hricak H13 107 91.6 97.4 Not mentioned Not mentioned 92%
Ricardo Manfredi,1 37 71.4 92.3 Not mentioned Not mentioned 89%
Sironi S21 56 94.4 92.1 Not mentioned Not mentioned 87.5%
Fatima et al 50 79 85 97 66 80%
Two patients had leiomyoma distorting uterine cavity. One
patient had retroverted uterus and one had adenomyosis. Two
percent cases of IA were overstaged as IIA on MRI, because
cervical stroma was not clearly seen on MRI due to
inflammation and it was predicted as stage IIA. Overall, MR
imagings sensitivity, specificity, diagnostic accuracy, and
positive and negative predictive values in assessing myometrial
infiltration were 88%, 83%, 97%, 50%, 88% respectively. MRI
also accurately staged presence of Cervical invasion in 8 (16%)
and absence of cervical invasion in 40 (80%) out of 50 patients.
One patient was underdiagnosed with cervical invasion. It was
IIB and was staged as IIA because of a small uterus. We
overstaged 1 case of IA as IIA, because cervical stroma was not
clearly seen on MRI due to inflammation and we predicted it
as stage IIA. Overall MR imaging sensitivity, specificity,
diagnostic accuracy, and positive and negative predictive
values in the assessment of cervical infiltration were, 64%,
66%, 65%, 91%, 25% respectively.
Discussion
Surgery is the treatment of choice in patients with
noninvasive or locally advanced endometrial carcinoma. In this
study, the capability of MR imaging was evaluated which can
help to predict all factors requested by the gynaecologic
oncologist to plan surgical treatment. Endometrial carcinoma
could be easily detected on T2-weighted MR images than the
detection on T1 weighted images because endometrial
relaxation time is equivalent to that of adjacent myometrium,
and therefore the two tissues appeared isointense on T1-
weighted images. Determining the presence and depth of
myometrial invasion is a highly critical factor, as is used in most
institutions to predict nodal metastases, since patients with 50%
or greater myometrial invasion have a six- to sevenfold
increased prevalence of pelvic and lumboaortic lymph node
metastases compared to patients with myometrial invasion in
whom is absent or less than 50%. The presence and depth of
myometrial infiltration can be assessed on T2-weighted images
as an interruption of the junctional zone, which appears
hypointense, contrary to endometrial adenocarcinoma, which
appears hyperintense. In postmenopausal women, however, the
junctional zone may be poorly visible and the myometrium may
be thinned due to uterine involution, making the presence and
depth of myometrial infiltration more difficult to assess. In fact,
in our series, the junctional zone was poorly visible in eight
patients. To overcome this limitation, dynamic MR imaging
should be performed, because it can depict different
enhancement times of the adenocarcinoma compared with
those of the adjacent myometrium, which improves in this
manner the contrast resolution of the tumour and myometrium.
In our series, by combining T2-weighted and dynamic MR
imaging, there was a significant correlation between MR
imaging and histopathologic findings in the assessment of
myometrial infiltration.
In this study we investigated only the local-regional
staging of endometrial adenocarcinoma, focusing on those
parameters that may change the surgical procedure for the
gynaecologist. The diagnostic accuracy of MRI is comparable
to that in previous publications (Table) with 79% sensitivity and
85% specificity. This represents, a limitation of this study, since
a complete work-up of these patients should include the search
for distant metastases or peritoneal implants. However,
malignant peritoneal cytologic findings are found in 12%-19%
of patients with endometrial carcinoma, and malignant
peritoneal cytologic features have not been prognostic in
women with early-stage disease. Another limitation of the study
is that some patients had their lymph node status determined
with histologic examination; the remaining lymph nodes were
assessed by means of palpation, which has a lower certainty
than histopathologic examination. Cases which were IB and
were staged as IA, because of bulky polypoid tumour distended
the endometrial cavity, thus attenuating the myometrium. One
patient had a small uterus less than 4cms in longitudinal
diameter and demonstrated marked thinning of myometrium.
Two patients had leiomyoma distorting the cavity and one
patient had retroverted uterus and another had adenomyosis.
One case of IA was overstaged as IIA on MRI because cervical
stroma was not clearly seen on MRI due to inflammation and it
was predicted as stage IIA. Limitations of the study were that
patients with II B, III A and IV disease were not present.
Conclusion
MR imaging coupled with contrast-enhanced dynamic
technique is highly accurate in local-regional staging of
endometrial carcinoma and can be used reliably for treatment
planning.
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